Naboctate

Naboctate (SP-325) is a synthetic cannabinoid receptor agonist, which has antiemetic, sedative, anxiolytic and anti-glaucoma properties.[1]

Naboctate
Identifiers
IUPAC name
  • (6,6,9-trimethyl-3-nonan-2-yl-7,8,9,10-tetrahydrobenzo[c]chromen-1-yl) 4-(diethylamino)butanoate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC33H53NO3
Molar mass511.791 g·mol−1
3D model (JSmol)
SMILES
  • CCCCCCCC(C)C1=CC2=C(C3=C(CCC(C3)C)C(O2)(C)C)C(=C1)OC(=O)CCCN(CC)CC
InChI
  • InChI=1S/C33H53NO3/c1-8-11-12-13-14-16-25(5)26-22-29(36-31(35)17-15-20-34(9-2)10-3)32-27-21-24(4)18-19-28(27)33(6,7)37-30(32)23-26/h22-25H,8-21H2,1-7H3
  • Key:UDQAWRWPAGUCRX-UHFFFAOYSA-N
  (verify)

References
  1. Morton IK, Hall JM (1999). Concise dictionary of pharmacological agents: properties and synonyms. Boston: Kluwer Academic. p. 188. ISBN 0-7514-0499-3.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.